13F

HUMA HUMACYTE INC

2026Q1 · CUSIP 44486Q103 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
156
Δ holders QoQ
+9
Breadth percentile
Top 31%
Whale holders
78
Δ whales
+4
Inst. holding value
$36M
New positions
34
Closed positions
25
Price momentum (1Q)
Put / Call
3/4

Breadth history (34 quarters)

2021Q4: Δ+29 · h=61 2022Q1: Δ+11 · h=72 2022Q2: Δ+7 · h=79 2022Q3: Δ-8 · h=71 2022Q4: Δ+5 · h=76 2023Q1: Δ-6 · h=70 2023Q2: Δ+5 · h=75 2023Q3: Δ+9 · h=84 2023Q4: Δ+5 · h=89 2024Q1: Δ+7 · h=96 2024Q2: Δ+27 · h=123 2024Q3: Δ+20 · h=143 2024Q4: Δ+19 · h=162 2025Q1: Δ+9 · h=171 2025Q2: Δ-12 · h=159 2025Q3: Δ-17 · h=142 2025Q4: Δ+5 · h=147 2026Q1: Δ+9 · h=156 2021Q4: holders=61 2022Q1: holders=72 2022Q2: holders=79 2022Q3: holders=71 2022Q4: holders=76 2023Q1: holders=70 2023Q2: holders=75 2023Q3: holders=84 2023Q4: holders=89 2024Q1: holders=96 2024Q2: holders=123 2024Q3: holders=143 2024Q4: holders=162 2025Q1: holders=171 2025Q2: holders=159 2025Q3: holders=142 2025Q4: holders=147 2026Q1: holders=156 -29 -14.5 +0 +14.5 +29 54117180 21Q422Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 5 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q3 Top 17% -20.4% -46.0%
2024Q2 Top 8% -25.3% -40.3%
2022Q2 Top 19%
2022Q1 Top 17%
2021Q4 Top 17%

Options Sentiment

Put holders
3
QoQ: 0
Call holders
4
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.63
EPS YoY
Revenue (TTM)
$0.0B
Revenue YoY
+289.9%
Quarterly Revenue & EPS (4Y)
2024-03-31: $0 2024-06-30: $0 2024-09-30: $0 2024-12-31: $0 2025-03-31: $517000 2025-06-30: $301000 2025-09-30: $753000 2025-12-31: $467000 2026-03-31: $495000 2022-06-30: EPS 0.35 2022-09-30: EPS -0.25 2022-12-31: EPS -0.03 2023-03-31: EPS -0.36 2023-06-30: EPS -0.22 2023-09-30: EPS -0.25 2023-12-31: EPS -0.24 2024-03-31: EPS -0.29 2024-06-30: EPS -0.48 2024-09-30: EPS -0.33 2024-12-31: EPS -0.16 2025-03-31: EPS 0.28 2025-06-30: EPS -0.24 2025-09-30: EPS -0.11 2025-12-31: EPS -0.19 2026-03-31: EPS -0.09 0 376500 753000 $ -0.53 -0.07 0.39 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)